Urology

Boston Scientific Lumenis Pulse™ 120H

This system operates with a Ho:YAG (holmium) laser source and has a wavelength of 2.1 µm.
Maximum optical power is 120 W, with energy ranging from 0.2–6.0 J per pulse and a repetition rate of 5–120 Hz.
The system includes patented “MOSES™” or “MOSES™ 2.0” pulse modulation technology, which optimizes energy delivery in urology procedures such as lithotripsy and benign prostatic hyperplasia (BPH) treatment, helping to reduce procedure time.
Laboratory studies with MOSES technology have shown that stone retropulsion can be reduced by approximately 50%, and fragmentation time by about 33%.
The system is designed for both stone disease treatment and BPH procedures, making it a versatile “one platform” solution in urology.

Rezūm Water Vapor Therapy is used in men with benign prostatic hyperplasia (BPH) to target enlarged prostate tissue, reduce its volume, and improve urine flow.
During the procedure, sterile water vapor (thermal energy) is delivered into the enlarged prostate tissue in 9-second treatment cycles, releasing energy as it cools and destroying tissue cells.
The procedure is minimally invasive, requires no incision, is often performed without general anesthesia, and allows patients to return to daily activities within a few days.
Clinical data show that many patients experience symptom improvement within 2 weeks, with maximum effect observed around 3 months.
Long-term outcomes are favorable, with a 5-year retreatment rate of approximately 4.4% and no significant negative impact on sexual function.

The AMS 700™ Inflatable Penile Prosthesis is designed based on both patient and surgeon needs, focusing on comfort and ease of use.
The new TENACIO™ Pump is engineered for an estimated 10-year implant life (approximately 1,000 activations).
InhibiZone™ Antibiotic Treatment technology helps reduce post-implant infection risk.
The system includes the MS (Momentary Squeeze) Pump™, which allows easy one-touch deflation.
It is available in different lengths and diameters (e.g., LGX, CX, CXR models) and is compatible with various surgical approaches (penoscrotal, infrapubic).
Clinical studies report approximately 95% patient satisfaction with sexual activity.
Link: https://www.priap.az/